What is Ureaplasma infection?
Ureaplasma infection is a condition caused by Ureaplasma species—small, wall‑less bacteria that naturally live in the genital and urinary tracts of many healthy adults. While most people carry these organisms without any problems, they can become pathogenic when the balance of normal flora is disturbed, when the immune system is weakened, or when the bacteria spread to areas where they do not belong (e.g., the upper reproductive tract, the bloodstream, or the eyes of newborns).
Ureaplasma belongs to the CDC‑recognized group of Mycoplasma‑like organisms. The two species most frequently implicated in human disease are Ureaplasma urealyticum and Ureaplasma parvum. Infection is usually diagnosed by a laboratory test that detects the organism’s DNA or by culturing a specimen from the urethra, cervix, or other relevant site.
Common Causes
Ureaplasma does not have a single “cause” in the same way that a virus does. Instead, several situations increase the likelihood that the bacteria will overgrow or spread, leading to infection:
- Sexual activity – unprotected vaginal, oral, or anal sex can transmit the organism between partners.
- Poor genital hygiene – excess moisture, tight clothing, or inadequate cleaning can foster bacterial growth.
- Pregnancy – hormonal changes and a more vascular genital tract make colonization easier.
- Use of intra‑uterine devices (IUDs) or other contraceptive devices – foreign bodies can alter the local environment.
- Urinary catheterization – catheters provide a direct conduit for bacteria to ascend the urinary tract.
- Antibiotic use – broad‑spectrum antibiotics may suppress competing flora, allowing Ureaplasma to dominate.
- Immunosuppression – conditions such as HIV, diabetes, or corticosteroid therapy reduce the body’s ability to keep the bacteria in check.
- Neonatal exposure – infants can acquire the organism during vaginal delivery, sometimes leading to conjunctivitis or pneumonia.
- Prolonged moist environments – swimming pools, hot tubs, or even chronic sweating can create a favorable niche.
- Co‑infection with other STIs – the presence of chlamydia, gonorrhea, or herpes can damage the mucosal barrier, facilitating Ureaplasma invasion.
Associated Symptoms
Because many carriers remain asymptomatic, the presence of symptoms often signals that the infection has moved beyond the lower genital tract. Commonly reported complaints include:
- Burning or itching during urination (dysuria)
- Pelvic or lower abdominal pain
- Painful sexual intercourse (dyspareunia)
- Unusual vaginal discharge (women) or penile discharge (men)
- Increased urinary frequency or urgency
- Lower back pain related to pelvic inflammatory disease (PID)
- Infertility or recurrent pregnancy loss (particularly in women)
- Preterm labor or premature rupture of membranes in pregnant women
- In newborns: eye redness, conjunctivitis, or respiratory distress
These symptoms overlap with other sexually transmitted infections (STIs), making laboratory testing essential for accurate diagnosis.
When to See a Doctor
Most Ureaplasma infections are mild and resolve with treatment, but you should seek medical attention promptly if you notice any of the following:
- Persistent burning or pain during urination lasting more than 48 hours
- Foul‑smelling or excessive genital discharge
- Pelvic pain that interferes with daily activities
- Fever, chills, or feeling generally unwell
- Signs of a possible pregnancy complication (e.g., cramping, bleeding, or a history of preterm birth)
- Newborn with eye redness or breathing difficulties
- History of infertility or recurrent miscarriage
Early evaluation can prevent complications such as pelvic inflammatory disease, epididymitis, or adverse pregnancy outcomes.
Diagnosis
Because Ureaplasma cannot be seen on a routine Gram stain, clinicians rely on specialized tests:
- NAAT (Nucleic Acid Amplification Test): The most sensitive method; a swab from the urethra, cervix, or urine sample is processed to detect bacterial DNA.
- Culture: Samples are placed on special media that support Ureaplasma growth. Results take 2‑5 days but can provide antibiotic‑susceptibility information.
- Serology: Blood tests for antibodies are rarely used because they do not reliably differentiate current infection from past exposure.
- Prenatal screening: Many obstetric clinics include Ureaplasma testing as part of routine STI panels during pregnancy.
Testing is usually performed after a clinical exam and after discussing sexual history, recent antibiotic use, and any relevant symptoms.
Treatment Options
Ureaplasma is susceptible to a limited group of antibiotics. Treatment choices depend on local resistance patterns, pregnancy status, and medication tolerance.
First‑line antibiotics
- Doxycycline 100 mg orally twice daily for 7 days (preferred for non‑pregnant adults).
- Azithromycin 1 g single dose or 500 mg daily for 3 days (alternative for patients who cannot take doxycycline).
Pregnancy‑safe options
- Azithromycin – safe in all trimesters.
- Erythromycin – used when azithromycin is unavailable, though gastrointestinal side effects are common.
Alternative or resistant cases
- Fluoroquinolones (e.g., levofloxacin) – reserved for confirmed resistant strains because of potential tendon toxicity.
- Josamycin or pristinamycin – available in some countries for multidrug‑resistant infections.
Home care & supportive measures
- Drink plenty of water to flush the urinary tract.
- Avoid irritants such as scented soaps, douches, or tight underwear.
- Complete the full antibiotic course even if symptoms improve.
- Abstain from sexual activity until both you and your partner have completed treatment and test negative.
- Use condoms consistently to reduce re‑exposure.
Prevention Tips
Because Ureaplasma is a common component of normal genital flora, eradication is unrealistic. However, the following measures can lower the risk of symptomatic infection and transmission:
- Practice safe sex – use condoms or dental dams for all sexual activities.
- Get regular STI screenings, especially if you have multiple partners or a new partner.
- Maintain genital hygiene – wash with mild, unscented soap and keep the area dry.
- Limit unnecessary antibiotic use – discuss alternatives with your doctor to avoid disrupting normal flora.
- Replace or clean catheters promptly and follow sterile technique when inserting urinary devices.
- Pregnant women should attend all prenatal visits where Ureaplasma testing may be offered.
- Partner notification – ensure sexual partners are treated simultaneously to prevent reinfection.
- Avoid smoking and excessive alcohol – both can impair immune function.
Emergency Warning Signs
If you or someone you care for experiences any of the following, seek emergency medical attention (e.g., go to the nearest emergency department or call 911):
- Severe abdominal or pelvic pain accompanied by fever (>38 °C / 100.4 °F).
- Rapidly worsening urinary symptoms with chills, shaking, or confusion – possible urosepsis.
- Sudden swelling, redness, or severe pain in the testicles (epididymitis) that does not improve.
- Pregnant woman with unexplained vaginal bleeding, severe cramping, or fluid leaking from the vagina (possible preterm labor).
- Newborn with profuse eye discharge, swelling, or difficulty breathing.
These signs indicate that the infection may be spreading or causing a serious systemic response and requires immediate evaluation.
**References**
- Mayo Clinic. “Ureaplasma infection.” mayoclinic.org. Accessed May 2026.
- Centers for Disease Control and Prevention. “Ureaplasma.” cdc.gov. Updated 2024.
- American College of Obstetricians and Gynecologists (ACOG). “Sexually Transmitted Infections in Pregnancy.” 2023.
- World Health Organization. “Guidelines for the management of sexually transmitted infections.” 2022.
- Cleveland Clinic. “Ureaplasma – Symptoms, Diagnosis, and Treatment.” 2024.
- National Institutes of Health. “Ureaplasma urealyticum and Ureaplasma parvum.” NIH Library, 2023.